Autologous Tenocytes Therapy to Improve the Healing Process of Tennis Elbow – A Preliminary Clinical Trail
Autologous Tenocytes Therapy to Improve the Healing Process of Tennis Elbow
Orthocell Pty Ltd
30 participants
Aug 15, 2007
Interventional
Conditions
Summary
The aim of this study is to assess the potential role of autologous tenocytes therapy in the healing process of tennis elbow.
Eligibility
Inclusion Criteria1
- History of tennis elbow longer than 6 months 2. Previously have received conservative treatment and not respond to the treatment.
Exclusion Criteria1
- Received steroid inject within the last 3 months.2. Previously have surgery intervention for tennis elbow 3. Any bone-muscular systematic disease like rheumatic disease, systemic lupus erythematous, ankylosing spondylosis.4. Any history of mental and psychological illness.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Autologous Tenocytes Injection Autologous tenocytes will be digested from a small epitendineum tissue (connective tissue on the surface of tendon) harvested from patients’ patellar tendon. After a period of in vivo cultivation, 2ml of autologous tenocytes at concentration of 3X106cell/ml will be inject into the elbow site where feel most pain.Patients will be rescheduled for follow-up appointment at 4 and 12 weeks after the injection. During any stage of this study, patients are obligation free to leave the experiment. Those chosen to leave will be referral to standard treatment.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000402448